Layer 1

Update Module 1559: Non-alcoholic fatty liver disease

Update Module 1559: Non-alcoholic fatty liver disease

How fatty livers cause diabetes, cirrhosis and cancer, and the implications for pharmacists' practice

60-second summary

Why read this module

Non-alcoholic fatty liver disease is an often overlooked complication of diabetes. This article details the potential risks associated with the condition and the implications for pharmacists.

What is non-alcoholic fatty liver disease?

Non-alcoholic fatty liver disease is defined as liver fat >5 per cent in the absence of other identifiable causes. It is the most common cause of chronic liver damage in western countries and around 70 per cent of patients with type 2 diabetes have fatty livers.

Why is it a problem?

It increases the risk of non-alcoholic steatohepatitis and hepatocellular carcinoma (HCC). It can cause cirrhosis, and doubles the risk of both chronic kidney disease and cardiovascular disease.

What should pharmacists

Want to read more ?

Login or Subscribe to Update Plus to continue reading our CPD content.

Job of the week

Pharmacist Manager
Midlands, Cheshire & Dorset
Salary dependent upon experience